Stay updated on Recombinant Protein Vaccine Clinical Trial
Sign up to get notified when there's something new on the Recombinant Protein Vaccine Clinical Trial page.

Latest updates to the Recombinant Protein Vaccine Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe webpage has been updated to include new information about the development of monovalent and bivalent SARS-CoV-2 vaccines by Sanofi Pasteur, including specific formulations and study cohorts for booster candidates. Additionally, several detailed objectives and criteria related to the study have been removed.SummaryDifference25%
- Check15 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 20, 2025.SummaryDifference0.2%
- Check22 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 20, 2025, and version 2.14.2.SummaryDifference0.1%
- Check44 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check58 days agoChange DetectedThe webpage has been updated with new information regarding the rSP-COVID19 formulations and their respective site number, while previous update dates and some service availability notices have been removed.SummaryDifference3%
- Check72 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
Stay in the know with updates to Recombinant Protein Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Protein Vaccine Clinical Trial page.